BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32565325)

  • 1. Reliable identification of cardiac liability in drug discovery using automated patch clamp: Benchmarking best practices and calibration standards for improved proarrhythmic assessment.
    Brinkwirth N; Takasuna K; Doi M; Becker N; Obergrussberger A; Friis S; Furukawa H; Hasegawa Y; Oka T; Ohtsuki A; Fertig N; Stoelzle-Feix S
    J Pharmacol Toxicol Methods; 2020 Sep; 105():106884. PubMed ID: 32565325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliable identification of cardiac conduction abnormalities in drug discovery using automated patch clamp II: Best practices for Nav1.5 peak current in a high throughput screening environment.
    Rotordam MG; Obergrussberger A; Brinkwirth N; Takasuna K; Becker N; Horváth A; Goetze TA; Rapedius M; Furukawa H; Hasegawa Y; Oka T; Fertig N; Stoelzle-Feix S
    J Pharmacol Toxicol Methods; 2021; 112():107125. PubMed ID: 34500078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Possible Proarrhythmic Potency: Comparison of the Effect of Dofetilide, Cisapride, Sotalol, Terfenadine, and Verapamil on hERG and Native IKr Currents and on Cardiac Action Potential.
    Orvos P; Kohajda Z; Szlovák J; Gazdag P; Árpádffy-Lovas T; Tóth D; Geramipour A; Tálosi L; Jost N; Varró A; Virág L
    Toxicol Sci; 2019 Apr; 168(2):365-380. PubMed ID: 30561737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of potency of HERG channel blockers: impact of voltage protocol and temperature.
    Yao JA; Du X; Lu D; Baker RL; Daharsh E; Atterson P
    J Pharmacol Toxicol Methods; 2005; 52(1):146-53. PubMed ID: 15936218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.
    Rampe D; Roy ML; Dennis A; Brown AM
    FEBS Lett; 1997 Nov; 417(1):28-32. PubMed ID: 9395068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o.
    Diaz GJ; Daniell K; Leitza ST; Martin RL; Su Z; McDermott JS; Cox BF; Gintant GA
    J Pharmacol Toxicol Methods; 2004; 50(3):187-99. PubMed ID: 15519905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a high-throughput electrophysiological assay for the human ether-à-go-go related potassium channel hERG.
    Gillie DJ; Novick SJ; Donovan BT; Payne LA; Townsend C
    J Pharmacol Toxicol Methods; 2013; 67(1):33-44. PubMed ID: 23103595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated electrophysiology in the preclinical evaluation of drugs for potential QT prolongation.
    Guo L; Guthrie H
    J Pharmacol Toxicol Methods; 2005; 52(1):123-35. PubMed ID: 15936217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of compound plate composition on measurement of hERG current IC(50) using PatchXpress.
    Mo ZL; Faxel T; Yang YS; Gallavan R; Messing D; Bahinski A
    J Pharmacol Toxicol Methods; 2009; 60(1):39-44. PubMed ID: 19442753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a hERG screen using the IonWorks HT: comparison to a hERG rubidium efflux screen.
    Sorota S; Zhang XS; Margulis M; Tucker K; Priestley T
    Assay Drug Dev Technol; 2005 Feb; 3(1):47-57. PubMed ID: 15798395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput electrophysiological assays for voltage gated ion channels using SyncroPatch 768PE.
    Li T; Lu G; Chiang EY; Chernov-Rogan T; Grogan JL; Chen J
    PLoS One; 2017; 12(7):e0180154. PubMed ID: 28683073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating dynamic protocol-dependence of hERG potassium channel inhibition at 37 degrees C: Cisapride versus dofetilide.
    Milnes JT; Witchel HJ; Leaney JL; Leishman DJ; Hancox JC
    J Pharmacol Toxicol Methods; 2010; 61(2):178-91. PubMed ID: 20172036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High throughput measurement of hERG drug block kinetics using the CiPA dynamic protocol.
    Windley MJ; Farr J; TeBay C; Vandenberg JI; Hill AP
    J Pharmacol Toxicol Methods; 2022; 117():107192. PubMed ID: 35750310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents.
    Gibson JK; Yue Y; Bronson J; Palmer C; Numann R
    J Pharmacol Toxicol Methods; 2014; 70(3):255-67. PubMed ID: 25219538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological analysis of mammalian cells expressing hERG using automated 384-well-patch-clamp.
    Haraguchi Y; Ohtsuki A; Oka T; Shimizu T
    BMC Pharmacol Toxicol; 2015 Dec; 16():39. PubMed ID: 26671227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated patch clamp in drug discovery: major breakthroughs and innovation in the last decade.
    Obergrussberger A; Friis S; Brüggemann A; Fertig N
    Expert Opin Drug Discov; 2021 Jan; 16(1):1-5. PubMed ID: 32646308
    [No Abstract]   [Full Text] [Related]  

  • 17. How in vitro influences in silico utilized for the prediction of in vivo - pilot study of the drug-induced pro-arrhythmic potency prediction.
    Badyra B; Lisowski B; Polak S; Kudolo J; Wiśniowska B
    Folia Med Cracov; 2015; 55(4):5-19. PubMed ID: 26867116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a [3H]astemizole binding assay in HEK293 cells expressing HERG K+ channels.
    Chiu PJ; Marcoe KF; Bounds SE; Lin CH; Feng JJ; Lin A; Cheng FC; Crumb WJ; Mitchell R
    J Pharmacol Sci; 2004 Jul; 95(3):311-9. PubMed ID: 15272206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel.
    Davie C; Pierre-Valentin J; Pollard C; Standen N; Mitcheson J; Alexander P; Thong B
    J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1302-9. PubMed ID: 15574182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on the advancing high-throughput screening techniques for patch clamp-based ion channel screens: implications for drug discovery.
    Obergrussberger A; Goetze TA; Brinkwirth N; Becker N; Friis S; Rapedius M; Haarmann C; Rinke-Weiß I; Stölzle-Feix S; Brüggemann A; George M; Fertig N
    Expert Opin Drug Discov; 2018 Mar; 13(3):269-277. PubMed ID: 29343120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.